Shanghai - Delayed Quote CNY

New China Life Insurance Company Ltd. (601336.SS)

49.51
-0.53
(-1.06%)
At close: 3:00:02 PM GMT+8
Loading Chart for 601336.SS
  • Previous Close 50.04
  • Open 49.92
  • Bid 49.50 x --
  • Ask 49.51 x --
  • Day's Range 49.32 - 50.04
  • 52 Week Range 28.51 - 58.03
  • Volume 12,235,731
  • Avg. Volume 21,319,455
  • Market Cap (intraday) 132.215B
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) 5.68
  • EPS (TTM) 8.72
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 1.39 (2.78%)
  • Ex-Dividend Date Nov 29, 2024
  • 1y Target Est --

New China Life Insurance Company Ltd. provides life insurance products and services to individuals and institutions in China. The company operates through three segments: Traditional insurance, Participating insurance, and Other Business. It provides life insurance, health insurance, and accident insurance products and services. The company also offers asset management, investment management, training, electronic commerce, and medical services; and invests in, develops, leases, and manages real estate properties. The company was incorporated in 1996 and is headquartered in Beijing, China.

www.newchinalife.com

28,675

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 601336.SS

View More

Performance Overview: 601336.SS

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

601336.SS
0.38%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

601336.SS
61.47%
SSE Composite Index (000001.SS)
5.95%

3-Year Return

601336.SS
97.23%
SSE Composite Index (000001.SS)
11.25%

5-Year Return

601336.SS
30.79%
SSE Composite Index (000001.SS)
15.43%

Compare To: 601336.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 601336.SS

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    133.63B

  • Enterprise Value

    123.26B

  • Trailing P/E

    5.74

  • Forward P/E

    10.21

  • PEG Ratio (5yr expected)

    0.42

  • Price/Sales (ttm)

    2.27

  • Price/Book (mrq)

    1.95

  • Enterprise Value/Revenue

    1.80

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    35.23%

  • Return on Assets (ttm)

    1.71%

  • Return on Equity (ttm)

    31.25%

  • Revenue (ttm)

    77.11B

  • Net Income Avi to Common (ttm)

    27.17B

  • Diluted EPS (ttm)

    8.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    531.75B

  • Total Debt/Equity (mrq)

    242.64%

  • Levered Free Cash Flow (ttm)

    -26.19B

Research Analysis: 601336.SS

View More

Company Insights: 601336.SS

Research Reports: 601336.SS

View More

People Also Watch